
We are delighted to welcome you to the 8th edition of the jointly organised EBMT and EHA European CAR T-cell Meeting, to be held in Palma de Mallorca, Spain from 12-14 February 2026.
Dear colleagues,
We are delighted to welcome you to the 8th edition of the jointly organised EBMT and EHA European CAR T-cell Meeting, to be held in Palma de Mallorca, Spain from 12-14 February 2026.
The promise of directing the immune system to precisely target malignancies is extraordinary, and clinical successes inspire for broader application. Yet, the path from concept to clinical reality remains complex, with challenges in manufacturing, delivery, long-term efficacy and safety.
This meeting will bring together key opinion leaders, experts and stakeholders to navigate through the evolving landscape of CAR T therapies, focusing on the clinical successes and challenges, the management of toxicities, highlighting mechanisms and strategies for long-term safety and efficacy, recent scientific innovations and new indications.
Building on the success of previous editions, the upcoming meeting will feature a comprehensive programme showcasing the latest scientific advances, clinical developments and real-world applications. We look forward to insightful discussions, meaningful connections, and continued progress in advancing patient care.
For those unable to attend in-person, the meeting will also be available virtually, with most of the sessions livestreamed via the virtual meeting platform. Whether you are a physician, scientist, industry representative, nurse, data manager, pharmacist, or patient advocate, this meeting offers a unique opportunity to engage with the forefront of CAR T-cell therapy development.
We look forward to welcoming you to what promises to be an inspiring event.
Yours sincerely,
Annalisa Ruggeri & Maria Themeli
Meeting Chairs
days
hours
minutes
seconds

Scientific Programme
Format
This is a Hybrid meeting, which can be attended in person or virtually. The emphasis lies on in-person participation in the programme, but most sessions will be live-streamed via a virtual platform for those who can only follow the programme remotely.
Target audience
The target audience is haematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient organisation representatives.
Programme
The meeting is led by Annalisa Ruggeri and Maria Themeli, in close collaboration with the Scientific Programme Committee (SPC). Together, they have created the programme and helped select speakers. The members are:
- Raffaella Greco (Italy)
- Stephan Mielke (Sweden)
- Natacha Bolaños (Spain)
- Alex Rampotas (United Kingdom)
- Julio Delgado (Spain)
- Ulrike Köhl (Germany)
- Mairéad Ni Chonghaile (Ireland)
- Jürgen Kuball (The Netherlands)
- Koray Yalcin (Türkiye)
- Chiara Bonini (Italy)
- Hilda Mekelenkamp (The Netherlands)
- Jana Pelouchova (Czech Republic)
#CART26

Abstracts & Grant Submission
Abstracts & Case Submission
It is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract and (if accepted) have the possibility to discuss it with the international faculty and your peers.
Please note that submitting an abstract constitutes a formal commitment by the author to attend the meeting in Palma de Mallorca, Spain (should the abstract be accepted). If requested, the author must also present the work as an oral or poster presentation during the assigned session and time slot in the scientific programme.
Introduced in 2021, we are excited to announce that there will be the 6th Emerging Investigators EBMT-EHA Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy. The Scientific Programme Committee will select three winners. Find more information here.
Oral presenting authors of accepted abstracts or cases will be allowed to register with the Early Bird registration discount fee, for which the details will be shared in the acceptance letter.
All other authors wishing to attend the meeting should complete their registration before 8 December 2025 (23:59 CET) to take advantage of the early registration discount fee.
Submission procedure
- The abstracts / clinical cases submitted via the submission portal will be reviewed and allocated by the Scientific Programme Committee (SPC).
Regular abstract/clinical case submission
- Submission duration: 10 July 2025 - 16 November 2025 (23:59 CET)
- Authors will be informed about the allocation by 26 November 2025
Late-breaker abstract/clinical case submission
Groundbreaking, high-impact research with recent, time-sensitive data that could not have been available during the regular submission period. It is not intended for work delayed due to time constraints, but for studies with the potential to significantly influence practice or advance science.
- Submission duration: 1 January 2026 - 11 January 2026 (23:59 CET)
- Authors will be informed about the allocation by 19 January 2026
Should you have any questions regarding the abstract submission or terms, please contact education.events@ebmt.org
Guidelines for the abstract/clinical case submission
The Abstract and Clinical Case Submission Guidelines of the 8th European CAR T-cell Meeting are intended to provide clear instructions before submitting an abstract. You are kindly requested to carefully read the guidelines.
- Text 400 words max
- They can be structured (e.g. Objectives, Methods, Results, Conclusions)
- Images have to be submitted as JPEG, TIF, or GIF file
- Due to limited space, only a simple graph/image can be submitted
- Image file should not exceed 500 KB
- Tables should be created as so
- Mention all the authors
- Disclosures and affiliation of all authors
- Authors: There is no limit to the number of authors
- References are obligatory when submitting an abstract or clinical case
Abstract and clinical case submission topics
- Access to CAR T
- Advanced Practice Roles within the Multidisciplinary team in CAR T Therapy
- CAR-based Cellular Therapy — Clinical: Biomarkers for CAR T efficacy and prediction model for response and toxicity
- CAR-based Cellular Therapy — Clinical: Challenges of CAR-based cellular therapy (bridging therapies and lymphodepletion), and clinical indication
- CAR-based Cellular Therapy — Clinical: Clinical investigations into therapeutic applications of CAR-T cell in oncology and other fields, adult/paediatric indications
- CAR-based Cellular Therapy — Clinical: Management of toxicities (early and late)
- CAR-based Cellular Therapy — Preclinical: CAR T cell manufacturing methodologies
- CAR-based Cellular Therapy — Preclinical: Innovative T cell engineering, CAR designs and optimization of CAR T cell function
- CAR-based Cellular Therapy — Preclinical: Mechanistic studies of CAR T efficacy and toxicities and tumour resistance
- CAR-based Cellular Therapy — Preclinical: Novel in vivo and in vitro models to functionally evaluate CAR T cells
- Clinical case on multiple myeloma
- Clinical case on new technologies for CAR T development
- Clinical case on solid tumours
- Models of Care and Multidisciplinary Collaboration in CAR T Programmes
- Perspectives in Adolescent and Young Adult (AYA) CAR T Care
- Quality of Life
- Real-world Nursing Practice in CAR T-cell Therapy
- Symptom Management and Toxicity Monitoring in CAR T Patients
Travel Grant Application Guidelines
Key dates
Dates | Items |
10 July 2025 | Travel grant application opens |
16 November 2025 (23:59 CET) | Travel grant application closes |
26 November 2025 | Notification of recipients |
8 December 2025 (23:59 CET) | Confirm acceptance |
Eligibility criteria:
- The applicant is 40 years of age or younger at the time of travel grant application.
- The applicant is an EBMT and/or EHA member or has applied for a membership by 5 November 2025.
- The 2025 membership fee has been paid by 16 November 2025.*
- A valid motivation letter with an up-to-date resume/CV.
*Only members who have paid their membership fee will be eligible for a discount on the registration fee. Check your EHA Membership by sending an e-mail to membership@ehaweb.org, or your EBMT membership by sending an email to membership@ebmt.org.
Application Process:
- Interested individuals can submit their application for the travel grant here.
- The travel grant applicant will be asked to confirm eligibility as per the above with a motivation letter (max. 2000 characters)
Selection:
- Only applications that meet the eligibility criteria will be considered.
- It is not mandatory to submit an abstract to the 8th European CAR T-cell Meeting, while abstract submitters of the meeting will have the priority to receive the grant.
- There are a limited number of travel grants for both European and non-European applicants.
Travel Grant Coverage:
European grant recipients:
- Complimentary registration arranged by EBMT/ EHA for on-site attendance
- Maximum of €750 for travel arrangements
- A reimbursement form must be completed (after the meeting), and the grant amount will be transferred after the meeting based on the attendance obligations.
Non-European grant recipients:
- Complimentary registration arranged by EBMT/EHA for on-site attendance
- Maximum of €1500 compensation for travel arrangements
- A reimbursement form must be completed (after the meeting), and the grant amount will be transferred after the meeting based on the attendance obligations.
Obligations of Grant Recipients:
- Grant recipients must confirm their acceptance by 8 December 2025, and provide any necessary documentation to facilitate the arrangements.
- Grant recipients must attend the full scientific meeting (sign-in will be required at the beginning of each day).
- Please note that the grant is non-transferable to other persons or meetings/congresses.
- Travel grant recipients must make their own travel arrangements (i.e. flight/train, hotel accommodation, etc.).
Deadline:
The deadline for travel grant application is 16 November 2025 (23:59 CET).
Notification:
Applicants will be notified of their travel grant status by 26 November 2025.
Any questions regarding the criteria, the application, or the procedure can be directed to education.events@ebmt.org.

Registration
To register, please click on the “Register” button above or click here.

(*) Accreditation/proof of status is required. Please note that registrants under the following categories will need to provide accreditation or proof of status in the form of an ID or a letter from their institution during the registration process: Nurses, Data Managers, Lab Technicians, Pharmacists, Psychiatrists/Phycologists, Quality Managers, Statisticians, Students/PhD Students (medical residents are not considered students), Transplant Coordinators, and Patient Advocates (Patient Advocates should provide a screenshot of their membership).
(**) Member of EBMT and/or EHA. Only members who have paid their membership fee are eligible to receive the discounted registration fee. Check your EBMT membership status by contacting membership@ebmt.org, or your EHA membership status by contacting membership@ehaweb.org.
The Junior EHA membership fee is only 20 Euro, click here for more information.
If you are not part of EBMT yet, please consider becoming an EBMT Member. For more information, visit this page.
Individual Registration
Hybrid registration includes:
- In-person access to all the sessions and activities according to the scientific programme
- Access to the virtual platform and livestream of scientific and educational sessions (according to the programme)
- 1 month of on-demand content from the platform (until 14 March 2026)
- Coffee breaks and lunch according to the programme
Virtual registration includes:
- Access to the virtual platform and livestream of scientific and educational sessions (according to the programme)
- 1 month of on-demand content from the platform (until 14 March 2026)
- NO possibility for Q&A with presenters
- NO access to the in-person poster session
- NO access to Industry Theatre sessions
Group Registration
If you would like to register a group (10 or more persons), please contact education.events@ebmt.org.
Press Registration
Press accreditation and registration is required to attend this meeting. Press registration is free and includes complimentary meeting registration. If you wish to register, please email communication@ehaweb.org and/or communications@ebmt.org with:
- a copy of your press credentials,
- a letter of assignment from the media organization being represented,
- two bylined medical/health/science articles published within the last 6 months.
Your credentials will be checked and when approved, you will receive a confirmation.
Media and Embargo Policy
Please find the Media and Embargo policy for the EBMT-EHA 8th European CAR T-cell Meeting here.
Name Changes
Name changes are permitted up to 15 days before the start of the meeting, and must be notified to education.events@ebmt.org. Please note that after that date, a fee will be required to process the name changes.
Cancellation Policy
All cancellations must be processed through the registration system, and notified to education.events@ebmt.org. The following refund conditions shall apply:
- If the cancellation is notified up to one month prior to the beginning of the meeting, your registration fee will be reimbursed in full (minus bank charges).
- If the cancellation is notified between 30 and 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (minus bank charges).
- For cancellations notified 15 days prior to the beginning of the meeting, the registration fee will not be refunded.
Certificate of Attendance
After the event, you will receive an email with a short survey to evaluate the course. Once you have completed it, you will be able to download the certificate of attendance.

Venue and Accommodation
Meeting Venue
Carrer de Felicià Fuster, 2, Llevant
07006 Palma de Mallorca, Balearic Islands (Spain)
Travel and Accommodation
Participants will be responsible for covering their travel and accommodation costs.
EBMT cannot accept liability for personal accidents or loss of or damage to the private property of participants. Participants are advised to arrange their own personal travel and health insurance for their trip.
Please ensure you have a valid passport/ID to travel to Spain. You may visit this official website to determine whether you need a visa to enter Spain. Should you require a visa letter, you will be able to download it after completing the registration process.

EBAH-CME Accreditation
We are pleased to announce that this educational course will be accredited by the EBAH-CME credits system (16 points).
In order to collect your EBAH-CME credits, we recommend that you create an EBAH-CME account by clicking here. By registering on the EBAH-CME website, you will have access to the record of all other events you have already been accredited for. After the meeting, an updated attendance list will be uploaded to the EBAH-CME website.
If you already have an account, you will receive an email to evaluate the course and claim your points. If after 15 days you have not received an email regarding your credits, please contact the EBMT Educational Events Unit at education.events@ebmt.org.

Sponsorship
There are various opportunities to support this meeting. For more information please send an email to fundraising@ebmt.org and/or sponsorship@ehaweb.org.
Deadlines

